SP Tulsian positive on Glenmark Pharma

SP Tulsian of sptulsian.com is positive on Glenmark Pharma.

Tulsian told CNBC-TV18, “I have a positive view on Glenmark Pharma because the results have been good, the guidance or the expectations also from the company going ahead is good. So Glenmark I have positive view.”
He further added, “The market has got disappointed with the Apollo Tyres numbers because it has not come in line with the CEAT and the MRF having posted by the company because if you see the year on year definitely there is disappointment. On quarter on quarter yes there has been improvement but the kind of expectation expected from the market leader in the tyre industry I think this has disappointed and if you see the trading positions having built up in the stock for last one month or so may be from the previous series that long positions have been there in the system. Infact this has- the behavior is identical to that of Arvind. I won't say that Arvind results have been on line with the Apollo Tyres. Infact Arvind has disappointed more. But this is the liquidation of the long positions which we have been seeing in the stock happening post results having posted by the company.”